We have examined human immunodeficiency virus type 1 (HIV-1) infection in chimpanzees by analyzing HIV-1 DNA and RNA in lymph nodes and peripheral mononuclear cells (PBMCs). Like certain asymptomatic HIV-infected persons, these chimpanzees had no detectable viral replication in their PBMCs. However, viral replication and a high viral load were observed in the lymphatic tissue. Despite the absence of viral replication in PBMCs, 1/1,000 to 1/10,000 of the PBMCs contained HIV-1 proviral DNA, and HIV transcription could be rapidly induced in these cells in vitro. These results provide direct evidence of cellular latency of HIV in vivo and suggest that HIV infection in chimpanzees may be a useful model for clinical latency of HIV infection in humans.
Chimpanzees can be infected with relatively low doses of human immunodeficiency virus type 1 (HIV-1), resulting in an infection that is in many ways similar to that of humans (1, 13, 19) . As in humans (29) , HIV-1 infection in chimpanzees results in a transient viremia followed by an extended period with low or undetectable levels of cell-free virus in plasma and few infected cells in the peripheral blood (14) (15) (16) . Chimpanzees also develop HIV-specific neutralizing antibodies (15, 25, 26) and cytotoxic T cells (4, 7, 39) . Despite these immunological responses, persistent viral replication occurs, and infectious virus can typically be isolated from chimpanzee peripheral blood mononuclear cells (PBMCs) at any time of the infection (2, 14, 15, 26) .
Although episodes of lymphadenopathy (1, 22) and cases of decreased numbers of CD4-positive lymphocytes accompanied by thrombocytopenia (18) have been reported, for reasons that are currently not well understood, none of the more than 100 chimpanzees infected with HIV-1 have so far have developed AIDS. Nevertheless, it is apparent that many features in the pathobiology of HIV infection are shared between humans and chimpanzees. The persistent infection in chimpanzees despite a specific immune response and the absence of overt disease suggests a virus-host interaction that might be similar to that in HIV-positive asymptomatic humans.
A lower level of viral gene expression (HIV-1 mRNA) and fewer HIV-infected cells (proviral DNA) are typically observed in the peripheral blood of HIV-infected persons during the asymptomatic phase of the disease than in later stages of the infection (3, 9, 23, 28, 34) . We have recently extended these observations by analyzing serial PBMC samples collected during a long-term prospective study. We found that the expression of HIV mRNA differs dramatically among HIVinfected individuals with very similar clinical indices, and this variation strongly correlates with the future course of their disease (32) . Significantly, we found no evidence of viral replication in the blood of long-term asymptomatic HIV * Corresponding author.
carriers who would continue to have normal numbers of CD4+ cells for more than 5 years.
Although HIV replication in PBMCs is variable over the course of the disease, it has been suggested that lymphoid germinal centers are an important reservoir of HIV and support active viral replication in all stages of HIV infection (8, 12, 27, 28) . Notably, high viral load has been demonstrated in the lymphatic tissues of asymptomatic individuals with little or no detectable viral replication in their peripheral blood (28) .
In all stages of the disease, the number of cells harboring HIV provirus appears to be larger than the number of cells expressing HIV-1 mRNA (8, 21, 35) . It is somewhat controversial whether this ratio significantly changes during the progression of the disease (3, 8, 23) ; if it does, a possible explanation could be an increase in the number of new productively infected cells rather than transcriptional activation of quiescent proviruses in latently infected cells. Therefore, it is not known whether latently infected cells which can be productively activated exist in vivo.
In 
MATERIALS AND METHODS
Chimpanzees. Chimpanzee C-487 (male) was infected intravenously with a chimpanzee-passaged lymphadenopathy-associated virus 1 (LAV-1) strain, LAV-lb (37), 4 .5 years before the analyzed samples were obtained and has been described in detail previously (14) . C-435 (male) was infected 3 years before sampling by transfusion of 7 x 105 PBMCs from another HIV-11,i-infected chimpanzee (C-087 in reference 20). A more detailed description of the infection and follow-up of C-435 is reported in reference 17. C-120 (female) was infected 10 months before sample collection via the endocervicalvaginal route, using an inoculum of 107 PBMCs from C-435. C-120 became virus positive in PBMCs at week 4 postinfection and seroconverted quickly thereafter. All chimpanzees were maintained in biosafety level 2 and 3 facilities at the Laboratory for Experimental Medicine and Surgery in Primates, and the experimental procedures were performed according to accepted practices for the care and use of primates in biomedical research.
Sample collection and preparation. Peripheral blood and inguinal LN biopsies were obtained simultaneously under ketamine anesthesia. The LN biopsies were frozen on dry ice and stored at -70°C until analyzed. PBMCs were purified immediately after the blood was drawn by using FicollHypaque (Pharmacia) centrifugation, washed twice with RPMI 1640, and either stored as a frozen pellet until analyzed or resuspended in RPMI 1640 with 10% fetal calf serum plus antibiotics when used for in vitro activation studies. These cells were kept at room temperature until split into aliquots and put into culture I h later. The unstimulated control sample was harvested at this point. Phorbol 12-myristate 13-acetate (PMA) and phytohemagglutinin (PHA) were purchased from Sigma and used as specified in the text.
Nucleic acid extractions and PCR assays. Total RNA was extracted by the acid phenol-guanidium isothiocyanate method (5). The RNA preparations were then treated for 1 h with 100 U of RNase-free DNase (Boehringer Mannheim) in the presence of 50 U of placental RNase inhibitor (Boehringer Mannheim), extracted with phenol-chloroform, and precipitated with ethanol. High-molecular-weight DNA was extracted by standard methods and incubated for 1 h with 100 U of boiled RNase A (Boehringer Mannheim) before addition of proteinase K to the lysates. The reverse transcription-PCR (RT-PCR) analysis of the RNA samples was performed as follows. One microgram of DNase-treated RNA in 20 p.l of water was heated for 5 min at 80°C, transferred onto ice, and combined with a mixture containing 6 pL. of (3, 000 Ci/mmol; NEN), and 0.25 p.1 of Taq polymerase (5 U/pl; Boehringer). These reactions were cycled in tightly fitting tubes under mineral oil in a Perkin-Elmer Cetus DNA Thermal Cycler 480 as follows: one cycle of 94°C for 40 s, 65°C for 1 min, and 72°C for 30 s, followed by 32 cycles of 94°C for 20 s, 65°C for 30 s, and 72°C for 20 s. r-Actin PCRs were cycled only 22 times after the first cycle, using the conditions specified above, and 10% dimethyl sulfoxide was added to inhibit primer-dimer formation. The sequences (sense and then antisense) of the oligonucleotides used were as follows: unspliced (US) HIV To confirm the lack of contaminating proviral HIV-1 DNA in the PBMC cDNA preparations, a duplicate cDNA synthesis of each sample was also performed without adding reverse transcriptase and analyzed in a US HIV-1 PCR assay. In addition, in each set of RNA extractions, a negative control with 20 p.g of yeast tRNA and no cells added to the lysis buffer was processed together with the PBMC preparations and analyzed in MS and US HIV-1 RT-PCR to exclude any contamination of the samples during sample processing or RT-PCR analysis. Quantitations of the HIV-1-specific RNA were based on comparisons of the intensities of the autoradiographic PCR signals from the chimpanzee samples with those derived from parallel analyses of in vitro-transcribed HIV-1 RNAs serially diluted into a constant amount (1 p.g) of HIV-negative human PBMC RNA (32) . For amplification of HIV-1 proviral sequences, I pLg of DNA in 2 pl was added to 50-pl PCR mixtures otherwise identical to those used to amplify cDNA specific for US HIV-1 RNA.
RESULTS
PBMCs and parts of LN were obtained from three HIV-1-infected chimpanzees, C-487, C-435, and C-120, and used for nucleic acid extractions (see Materials and Methods). HIVspecific DNA and RNA were measured by PCR and RT-PCR with two different sets of amplification primers that match precisely the HIV-lLai sequence of the viral strains used to infect the animals. One set of primers was located on each side of the major splice donor site in the 5' region of the virus and was used to amplify a 160-bp fragment specific for HIV proviral DNA and cDNA derived from US HIV RNA. US HIV RNA could represent genomic RNA in viral particles or intracellular full-length HIV mRNA. Another set of primers separated by the intron between the two coding exons of tat and rev was used to amplify a 131-bp fragment from cDNA representing MS HIV mRNA. MS HIV mRNA is obligately intracellular and therefore reflects ongoing viral replication. To control for the quantity and quality of the RNA preparations and the efficiency of subsequent cDNA synthesis, RT-PCR specific for 1-actin mRNA was also performed.
As shown in Fig. IA , no MS HIV-1 RNA was detected in the PBMC samples from any of the three chimpanzees (Fig. IA , lanes P), indicating less than 50,000 molecules of MS HIV-1 mRNA per microgram of total PBMC RNA. Similarly, little or no US HIV RNA was observed in the PBMCs. In longer exposures of the autoradiogram, a weak signal specific for US HIV RNA was seen in PBMCs from chimpanzee 435 (not shown), whereas samples from the others (chimpanzees 487 and 120) were still negative. In the absence of MS HIV mRNA, however, the low levels of US HIV mRNA signal in the PBMC sample of chimpanzee 435 is unlikely to reflect HIV replication and probably was caused by virus particles produced elsewhere in the animal. The intensities of 1-actin mRNA signals from all PBMC samples were comparable and similar to what we typically observe when using cDNA prepared from 1 to 2 pLg of spectrophotometrically quantitated human PBMC RNA, indicating that the chimpanzee PBMC RNAs were intact and the cDNA synthesis had been successful. Thus, no evidence of viral replication in the PBMCs of these animals was observed.
In contrast, intense autoradiographic signals specific for US HIV RNA were detected in LN samples from all three animals (Fig. 1) . This was even more striking considering that two of these LN RNA preparations (435 and 120) had much less intact RNA, as indicated by the weak 3-actin signal obtained from these cDNAs (Fig. 1) . From results for our in vitro- 435 and 120 could not be assessed because of the poor quality of these RNA preparations. Nevertheless, the result clearly demonstrates that active viral replication can occur in the lymphatic tissues of HIV-infected chimpanzees even when it is not detectable in the peripheral blood.
The amount of MS HIV-1 RNA in the LN of chimpanzee 487 was, however, less than 1% of that of US HIV-1 RNA. Such a dramatic difference in the ratio of these differentially spliced HIV RNAs is probably due to the fact that most of the US HIV RNA signal is derived from viral particles trapped in the LN and not from intracellular full-length HIV mRNA. This interpretation is in agreement with published in situ hybridization studies showing that most of the abundant HIV RNA present in the LN of HIV-infected humans is located extracellularly associated with the dendritic follicular cells (8, 28) .
To examine the relative numbers of HIV-infected cells, genomic DNA was prepared from the PBMCs of chimpanzee 487 and from another part of the same LN of this animal that had been analyzed for its HIV RNA content. One microgram of each DNA was then used as the template for PCR amplification employing the primers and reaction conditions established for the US RT-PCR assay. The number of HIV-1 proviruses per microgram of genomic DNA was found to be approximately 10-fold higher in the lymphatic tissue than in the PBMCs (Fig. 1B) . A similar ratio was observed between the LN and PBMCs of another chimpanzee (animal 411; data not shown) for which no LN RNA was available for RT-PCR analysis. Thus, the increased expression of HIV-1 RNA in the lymph nodes of HIV-infected chimpanzees is accompanied by a higher number of proviruses than in their peripheral blood.
Although we found no evidence of viral replication in the peripheral blood, the intensity of HIV-specific DNA signal suggested that 1/1,000 to 1/10,000 of the PBMCs of chimpanzee 487 carried a provirus. To test whether viral replication could be induced in these cells by cellular activation, we collected a larger blood sample from this animal and analyzed HIV-1 mRNA expression in these PBMCs before and after stimulation in vitro with 100 nM PMA and 2 ,ug of PHA per ml. This second blood sample, collected more than 6 months after the first, confirmed the lack of HIV mRNA expression in the unstimulated PBMCs and indicated that this phenotype is stable over time. However, after only 12 h of stimulation in vitro, HIV gene expression was evident, and both MS and US HIV-1 mRNAs were readily detected by RT-PCR (Fig. 2) (33) .
The PMA-PHA-induced activation of latent HIV in chimpanzee PBMCs was similar to the proviral activation observed in certain cell line models of HIV latency (10, 11) . These latently infected cell lines have been derived from single cells which have survived the lytic effects of HIV after infection of human T-cell and monocytic leukemia cell cultures. Such cell lines support only very low levels of viral replication when cultured in an unstimulated state but can be induced to produce high amounts of virus when exposed to agents such as PMA and PHA or cytokines such as tumor necrosis factor alpha. The increased virus production after such stimulation of these cells is accompanied by a highly induced expression of HIV mRNA (31) . Much of this induction is believed to be mediated by interaction of the transcription factor NF-KB with its two tandemly arranged cognate sites in the proviral long terminal repeat element (6, 24) . Thus, it is likely that the increased activity of NF-KB, or a closely related factor, is involved in the activation of latent HIV in the in vitrostimulated chimpanzee PBMCs. Transcriptional quiescence of integrated proviruses, however, may not be the only molecular mechanism of HIV cellular latency. It (36, 38) . Our findings do not exclude a role for such a preintegration form of HIV latency. Nevertheless, the present results directly demonstrate the existence of cellular latency of HIV in vivo and provide a useful model with which to further dissect the molecular mechanism involved.
